Treatment of adult depression in the United States

JAMA Internal Medicine

Volumn 176, Issue 10, 2016, Pages 1482-1491

  Olfson, Mark ^a   Blanco, Carlos ^b   Marcus, Steven C ^c  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISTRESS SYNDROME; FEMALE; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MIDDLE AGED; PATIENT HEALTH QUESTIONNAIRE 2; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOTHERAPY; UNITED STATES; YOUNG ADULT; ADOLESCENT; DRUG UTILIZATION; EDUCATIONAL STATUS; GENERAL PRACTITIONER; HEALTH CARE SURVEY; INSURANCE; MARRIAGE; MASS SCREENING; MEDICALLY UNINSURED; MENTAL STRESS; PSYCHIATRY; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADULT; AGED; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; DEPRESSION; DRUG UTILIZATION; EDUCATIONAL STATUS; FEMALE; GENERAL PRACTITIONERS; HEALTH CARE SURVEYS; HUMANS; INSURANCE COVERAGE; MALE; MARITAL STATUS; MASS SCREENING; MEDICALLY UNINSURED; MIDDLE AGED; PSYCHIATRY; PSYCHOTHERAPY; STRESS, PSYCHOLOGICAL; UNITED STATES; YOUNG ADULT;

EID: 84997514536     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2016.5057     Document Type: Article

References (52)

1. Hasin DS, Goodwin RD, Stinson FS, Grant BF. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry. 2005;62(10):1097-1106.
2. Kessler RC, Berglund P, Demler O, et al; National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095-3105.
3. Mojtabai R, Olfson M. National trends in long-term use of antidepressant medications: results from the U.S. National Health and Nutrition Examination Survey. J Clin Psychiatry. 2014;75(2): 169-177.
4. IMS. Top therapeutic Classes by US Dispensed Prescriptions. http://www.imshealth.com/en/about-us/news/top-line-market-data. Accessed January 15, 2016.
5. Siu AL, Bibbins-Domingo K, Grossman DC, et al; US Preventive Services Task Force (USPSTF). Screening for depression in adults: US preventive services task force recommendation statement. JAMA. 2016;315(4):380-387.
6. National Collaborating Centre for Mental Health. Depression: the treatment and management of depression in adults: NICE clinical guideline 90. London: National Institute for Health and Clinical Excellence; 2009.
7. New Zealand Guidelines Group. Identification of common mental disorders and management of depression in primary care. Wellington: New Zealand Guidelines Group; 2008.
8. Mead GE, Morley W, Campbell P, Greig CA, McMurdo M, Lawlor DA. Exercise for depression. Cochrane Database Syst Rev. 2008;(4):CD004366.
9. Cramer H, Lauche R, Langhorst J, Dobos G. Yoga for depression: a systematic review and meta-analysis. Depress Anxiety. 2013;30(11): 1068-1083.
10. Patten SB, Kennedy SH, Lam RW, et al; Canadian Network for Mood and Anxiety Treatments (CANMAT). Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. I. Classification, burden and principles of management. J Affect Disord. 2009;117 (suppl 1):S5-S14.
11. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: ameta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 2008;5(2):e45. doi:10.1371/journal.pmed.0050045.
12. Barbui C, Cipriani A, Patel V, Ayuso-Mateos JL, van Ommeren M. Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis. Br J Psychiatry. 2011;198(1):11-16, 1.
13. von Wolff A, Hölzel LP, Westphal A, Härter M, Kriston L. Combination of pharmacotherapy and psychotherapy in the treatment of chronic depression: a systematic review and meta-analysis. BMC Psychiatry. 2012;12:61.
14. van der Feltz-Cornelis CM, Van Os TW, Van Marwijk HW, Leentjens AF. Effect of psychiatric consultation models in primary care. A systematic review and meta-analysis of randomized clinical trials. J Psychosom Res. 2010;68(6):521-533.
15. Weiss C, Connor S, Ward P, DiGaetano R, Machlin S, Wun L-M. Report on interim nonresponse subsampling for MEPS Panel 16-Agency for Healthcare Research and Quality working paper no.13001. 2013 https://meps.ahrq.gov/data-files/publications/workingpapers/wp-13001.pdf. Accessed January 15, 2016.
16. Agency for Healthcare Research and Quality. Medical Expenditure Panel Survey, MEPS survey questionnaires, household questionnaire sections. Rockville, MD: Department of Health and Human Services https://meps.ahrq.gov/mepsweb/survey-comp/survey.jsp. Accessed January 15, 2016.
17. Wun LM, Ezzati-Rice TM, Diaz-Tena N, Greenblatt J. On modelling response propensity for dwelling unit (DU) level non-response adjustment in the Medical Expenditure Panel Survey (MEPS). Stat Med. 2007;26(8):1875-1884.
18. Agency for Healthcare Research and Quality. MEPS HC-036: 1996-2012-pooled linkage variance estimation file. October 2014 https://meps.ahrq.gov/data-stats/download-data-files-detail.jsp. Accessed January 15, 2016.
19. Kroenke K, Spitzer RL, Williams JBW. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41 (11):1284-1292.
20. Löwe B, Kroenke K, Gräfe K. Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res. 2005;58 (2):163-171.
21. Arroll B, Goodyear-Smith F, Crengle S, et al. Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. Ann Fam Med. 2010;8(4):348-353.
22. Kessler RC, Green JG, Gruber MJ, et al. Screening for serious mental illness in the general population with the K6 screening scale: results from the WHOWorld Mental Health (WMH) survey initiative. Int JMethods Psychiatr Res. 2010;19(suppl 1):4-22.
23. Kessler RC, Andrews G, Colpe LJ, et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med. 2002;32(6):959-976.
24. Kessler RC, Barker PR, Colpe LJ, et al. Screening for serious mental illness in the general population. Arch Gen Psychiatry. 2003;60(2):184-189.
25. Sakurai K, Nishi A, Kondo K, Yanagida K, Kawakami N. Screening performance of K6/K10 and other screening instruments for mood and anxiety disorders in Japan. Psychiatry Clin Neurosci. 2011;65 (5):434-441.
26. Wang PS, Berglund P, Olfson M, Pincus HA, Wells KB, Kessler RC. Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6): 603-613.
27. Woltmann E, Grogan-Kaylor A, Perron B, Georges H, Kilbourne AM, Bauer MS. Comparative effectiveness of collaborative chronic care models for mental health conditions across primary, specialty, and behavioral health care settings: systematic review and meta-analysis. Am J Psychiatry. 2012;169(8):790-804.
28. Mitchell AJ, Vaze A, Rao S. Clinical diagnosis of depression in primary care: ameta-analysis. Lancet. 2009;374(9690):609-619.
29. Simon GE, Rossom RC, Beck A, et al. Antidepressants are not overprescribed for mild depression. J Clin Psychiatry. 2015;76(12): 1627-1632.
30. Cuijpers P, Koole SL, van Dijke A, Roca M, Li J, Reynolds CF III. Psychotherapy for subclinical depression: meta-analysis. Br J Psychiatry. 2014; 205(4):268-274.
31. Barth J, Munder T, Gerger H, et al. Comparative efficacy of seven psychotherapeutic interventions for patients with depression: a network meta-analysis. PLoS Med. 2013;10(5):e1001454.
32. Driessen E, Cuijpers P, Hollon SD, Dekker JJ. Does pretreatment severity moderate the efficacy of psychological treatment of adult outpatient depression? Ameta-analysis. J Consult Clin Psychol. 2010;78(5):668-680.
33. Lee SY, Franchetti MK, Imanbayev A, Gallo JJ, Spira AP, Lee HB. Non-pharmacological prevention of major depression among community-dwelling older adults: a systematic review of the efficacy of psychotherapy interventions. Arch Gerontol Geriatr. 2012;55(3):522-529.
34. Gum AM, Areán PA, Hunkeler E, et al. Depression treatment preferences in older primary care patients. Gerontologist. 2006;46(1):14-22.
35. Arean PA, Hegel MT, Reynolds CF. Treatment depression in older medical patients with psychotherapy. J Clin Geropsychol. 2001;7:93-104.
36. Unützer J, Katon W, Callahan CM, et al; IMPACT Investigators. Improving Mood-Promoting Access to Collaborative Treatment. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA. 2002;288(22):2836-2845.
37. Cuijpers P, Dekker J, Hollon SD, Andersson G. Adding psychotherapy to pharmacotherapy in the treatment of depressive disorders in adults: ameta-analysis. J Clin Psychiatry. 2009;70(9): 1219-1229.
38. Craighead WE, Dunlop BW. Combination psychotherapy and antidepressant medication treatment for depression: for whom, when, and how. Annu Rev Psychol. 2014;65:267-300.
39. Lorant V, Deliège D, Eaton W, Robert A, Philippot P, Ansseau M. Socioeconomic inequalities in depression: ameta-analysis. Am J Epidemiol. 2003;157(2):98-112.
40. Trivedi MH, Rush AJ, Wisniewski SR, et al; STAR∗D Study Team. Evaluation of outcomes with citalopram for depression using measurementbased care in STAR∗D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28-40.
41. Fournier JC, DeRubeis RJ, Shelton RC, Hollon SD, Amsterdam JD, Gallop R. Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression. J Consult Clin Psychol. 2009;77(4):775-787.
42. Wang PS, Demler O, Olfson M, Pincus HA, Wells KB, Kessler RC. Changing profiles of service sectors used for mental health care in the United States. Am J Psychiatry. 2006;163(7): 1187-1198.
43. Bauer AM, Azzone V, Alexander L, Goldman HH, Unützer J, Frank RG. Are patient characteristics associated with quality of depression care and outcomes in collaborative care programs for depression? Gen Hosp Psychiatry. 2012;34(1):1-8.
44. Steel Z, McDonald R, Silove D, et al. Pathways to the first contact with specialist mental health care. Aust N Z J Psychiatry. 2006;40(4):347-354.
45. Gilman SE, Fitzmaurice GM, Bruce ML, et al. Economic inequalities in the effectiveness of a primary care intervention for depression and suicidal ideation. Epidemiology. 2013;24(1):14-22.
46. Nelson JC, Papakostas GI. Atypical antipsychotic augmentation in major depressive disorder: ameta-analysis of placebo-controlled randomized trials. Am J Psychiatry. 2009;166(9): 980-991.
47. Furukawa TA, Streiner DL, Young LT. Antidepressant and benzodiazepine for major depression. Cochrane Database Syst Rev. 2002;1(1): CD001026.
48. Valenstein M, Taylor KK, Austin K, Kales HC, McCarthy JF, Blow FC. Benzodiazepine use among depressed patients treated in mental health settings. Am J Psychiatry. 2004;161(4):654-661.
49. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder. 3rd ed. Arlington, VA: American Psychiatric Association; 2010.
50. Vigo DV, Baldessarini RJ. Anticonvulsants in the treatment of major depressive disorder: an overview. Harv Rev Psychiatry. 2009;17(4):231-241.
51. Mojtabai R. Clinician-identified depression in community settings: concordance with structured-interview diagnoses. Psychother Psychosom. 2013;82(3):161-169.
52. Marcus SC, Olfson M. National trends in the treatment for depression from 1998 to 2007. Arch Gen Psychiatry. 2010;67(12):1265-1273.